0001181431-13-030749.txt : 20130524 0001181431-13-030749.hdr.sgml : 20130524 20130524164956 ACCESSION NUMBER: 0001181431-13-030749 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130523 FILED AS OF DATE: 20130524 DATE AS OF CHANGE: 20130524 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pascoe Richard W CENTRAL INDEX KEY: 0001343266 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22245 FILM NUMBER: 13872707 MAIL ADDRESS: STREET 1: C/O SOMAXON PHARMACEUTICALS, INC. STREET 2: 10935 VISTA SORRENTO PARKWAY, SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: APRICUS BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001017491 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870449967 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11975 EL CAMINO REAL, STREET 2: SUITE 300 CITY: SAN DIEGO, STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 222-8041 MAIL ADDRESS: STREET 1: 11975 EL CAMINO REAL, STREET 2: SUITE 300 CITY: SAN DIEGO, STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: NEXMED INC DATE OF NAME CHANGE: 19970311 4 1 rrd381345.xml FORM 4 X0306 4 2013-05-23 0 0001017491 APRICUS BIOSCIENCES, INC. APRI 0001343266 Pascoe Richard W 11975 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 1 1 0 0 Chief Executive Officer Common Stock 2013-05-23 4 P 0 35000 2.85 A 35000 D Common Stock Warrant 3.40 2013-05-23 4 P 0 35000 2.85 A 2013-05-29 2018-05-29 Common Stock 17500 35000 D Purchase in accordance with the Underwriting Agreement, by and between Apricus Biosciences, Inc. and Lazard Capital Markets LLC, dated May 23, 2013. Each warrant is exercisable for 0.50 shares of common stock. /s/ Richard W. Pascoe 2013-05-24